Abbott Laboratories vs Sera Investments & Finance India: Fair Value & Quality
Both stocks run through our valuation models. Here is how Abbott Laboratories (ABT) and Sera Investments & Finance India (SERA) compare, as of Sep 6, 2026.
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Sera Investments & Finance India leads: 2 to 7 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
What the models say
How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.
▲above the price, more than 15% above ●close to the price, 85% to 115% of the price ▼below the price, more than 15% below
| Model family | Abbott LaboratoriesPrice $108 | Sera Investments & Finance IndiaPrice ₹56.19 |
|---|---|---|
| DCF Models | ▼-33%below the price$73.01 | n/a |
| Earnings-Based | ▼-73%below the price$29.42 | n/a |
| Dividend Discount | ▼-63%below the price$39.73 | n/a |
| Multiples | ▼-35%below the price$70.72 | ▲+51%above the price₹84.59 |
| Asset-Based | ▼-81%below the price$20.05 | ▼-47%below the price₹30.06 |
| Growth DCF | ▼-38%below the price$67.02 | n/a |
| Economic Profit | ▼-65%below the price$37.49 | ▲+23%above the price₹69.36 |
| Growth Earnings | ▼-35%below the price$70.25 | n/a |
| Minimum | ▼-81%below the price$20.05 | ▼-47%below the price₹30.06 |
| Maximum | ▼-33%below the price$73.01 | ▲+51%above the price₹84.59 |
| Median | ▼-51%below the price$53.37 | ▲+23%above the price₹69.36 |
| Geometric mean | ▼-57%below the price$46.36 | ●0%close to the price₹56.08 |
Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.
Abbott Laboratories: 26 of 26 models see the stock below the current price.
Sera Investments & Finance India: 1 of 4 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Compare two other stocks
Tap a field and type again, ticker or company name.
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Abbott Laboratories · Health Care
Sera Investments & Finance India · Financials
Bottom line
As of Sep 6, 2026, Fair Value Calculator sees Sera Investments & Finance India as the more attractively valued of the two: Abbott Laboratories trades at $108 versus a fair value of $74.79 (-31%), while Sera Investments & Finance India trades at ₹56.19 versus ₹84.55 (+50%).
Sera Investments & Finance India has the higher quality score (69/100).
See the full analysis →More comparisons
Popular match-ups from the same sectors, all with fair value and quality score.
Related to Abbott Laboratories
Abbott Laboratories vs UnitedHealth GroupEli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupRelated to Sera Investments & Finance India
Alphabet Inc Class C vs Verizon CommunicationsAlphabet Inc Class C vs At&tAlphabet Inc Class C vs NetEaseAmazon.com vs PDD HoldingsSee the undervalued quality stocks every month
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.